Diagnostic performance of the ClearLLab 10C B cell tube.
INTRODUCTION
Pre-analytical and analytical errors can threaten the reliability of flow cytometry (FC) results. A potential solution to some of these is the use of dry, pre-mixed antibodies, such as the ClearLLab 10C system. The purpose of the present study was to compare the diagnostic performance of the ClearLLab 10C B cell tube with that of our standard laboratory practice.


METHODS
We compared the diagnoses made with the ClearLLab 10C B cell tube (experimental strategy) with those made with standard laboratory practice (standard strategy). Samples were selected aiming for representation of the full spectrum of B cell disorders, with an emphasis on mature B cell malignancies, as well as healthy controls.


RESULTS
We included 116 samples (34 normal controls, 4 acute lymphoblastic leukemias, 54 mature lymphoproliferative disorders in peripheral blood and bone marrow, 3 myelomas, 6 bone marrow samples with involvement by lymphoma and 1 with elevated hematogone count, 14 lymph node samples, 1 cerebrospinal fluid, and 1 pleural effusion). There were two diagnostic errors (1.7%). The agreement between the two strategies in the percentage of CD19 cells and fluorescence intensity of CD5, CD19, CD20, CD200, and CD10 was very good.


CONCLUSIONS
In this study, the ClearLLab 10C B cell tube performed similarly to our standard laboratory practice to diagnose and classify mature B cell malignancies.
['Espasa|Andrea|A|', 'Torrents|Silvia|S|', 'Morales-Indiano|Cristian|C|', 'Rico|Laura G|LG|', 'Bardina|Jorge|J|', 'Ancochea|Agueda|A|', 'Bistué-Rovira|Àngel|À|', 'Linio|Rosa|R|', 'Raya|Minerva|M|', 'Vergara|Sara|S|', 'Juncà|Jordi|J|', 'Grifols|Joan-Ramon|JR|', 'Petriz|Jordi|J|', 'Soria|Maria-Gloria|MG|', 'Sorigue|Marc|M|0000-0002-0587-591X']
B cells flow cytometry ALL chronic lymphocytic leukemia lymphoma, lymphoproliferative disorder, multiple myeloma